Cl.[CH2:2]([NH:4][CH2:5][CH3:6])[CH3:3].[CH3:7][C:8]1[CH:17]=[N:16][C:15]2[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=2)[N:9]=1.[CH2:18]=O.Cl>C(O)C.O.C(N(CC)CC)C>[NH3:4].[CH2:2]([N:4]([CH2:5][CH3:6])[CH2:18][CH2:7][C:8]1[CH:17]=[N:16][C:15]2[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=2)[N:9]=1)[CH3:3]A solution of diethylamine hydrochloride (3.82 g, 35 mmol) and triethylamine (0.23 ml) in ethanol (1.75 ml) and water (1.75 ml) was added dropwise, at 60° C., to a mixture of 2-methyl-quinoxaline (5.0 g, 35 mmol), formaldehyde (2.81 g of 37% solution, 35 mmol), triethylamine (0.17 ml) and ethanol (4.6 ml). The pH was adjusted to 7–7.5 by mean of dilute aqueous hydrochloric acid. Stirring was maintained 16 hours at 60° C. The solvent was concentrated, the residue was diluted with water and extracted with diethyl ether to remove the unreacted quinoxaline. The aqueous phase was basified with 20% aqueous sodium hydroxide (10 ml) and extracted with ethyl acetate. The organic phase was dried over magnesium sulfate and concentrated. The residue was chromatographed on silica gel eluting with dichloromethane-methanol (first 95-5 then 90-10 and finally 90-10 plus 0.1% of ammonia) to give diethyl-(2-quinoxalin-2-yl-ethyl)-amine (2.67 g, 37%).